Matthew Lenhard
Obstetrics & Gynecology · Columbia, SCNPI 1467681965
Payments from drug & device makers
Across 99 payments — averaging $54.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Meditrina$367
- Astellas Pharma US Inc$176
- Millicent US Inc$151
- Myriad Women's Health, Inc.$113
- AbbVie$111
- plus $1K from 23 others
What the payments were for
- Speaking & faculty fees$3506%
- Travel & lodging$1904%
- Food & beverage$1,89335%
- Education$3,00055%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 12 | $3,442 |
| Meditrina | 2 | $367 |
| Astellas Pharma US Inc | 9 | $176 |
| Millicent US Inc | 8 | $151 |
| Myriad Women's Health, Inc. | 1 | $113 |
| AbbVie | 7 | $111 |
| Mayne Pharma Commercial LLC | 10 | $109 |
| Bayer | 6 | $104 |
| Bausch Health US, LLC | 5 | $84 |
| Baxter Healthcare | 1 | $82 |
| Pfizer | 4 | $69 |
| Coopersurgical, Inc. | 3 | $66 |
| Exeltis, USA Inc. | 3 | $66 |
| Myovant Sciences Inc. | 4 | $65 |
| Scynexis, Inc. | 3 | $59 |
| Sage Therapeutics, LLC | 2 | $45 |
| Organon | 2 | $40 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Convatec Inc. | 2 | $38 |
| Shield Therapeutics Inc | 2 | $31 |
| Minerva Surgical, Inc | 2 | $31 |
| Evofem Biosciences, Inc. | 2 | $27 |
| Mycovia Pharmaceuticals, Inc. | 1 | $19 |
| Mylan Pharmaceuticals Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $19 |
| Exact Sciences | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Axonics, Inc. | 1 | $15 |
| Aspira Women's Health Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$3,000
- Da Vinci Surgical System$178
- myRisk$113
How this compares
$5,434 in reported general payments places this provider in the 85th percentile of 673 obstetrics & gynecology providers in South Carolina.
See all obstetrics & gynecology providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 11 | $5,453 |
| Estradiol | 26 | $2,092 |
| Metronidazole | 11 | $129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $176 | $5,45311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 673 obstetrics & gynecology providers in South Carolina.
Other obstetrics & gynecology in Columbia
- Meghan HillColumbia$795K
- Adrian BalicaColumbia$174K
- Orson RavenellColumbia$68K
- Judith BurgisColumbia$59K
- Ana RodriguezColumbia$9K
- Patricia SealColumbia$7K
- Robert LondonColumbia$7K
- Christopher JenningsAnderson$1.3M
- George HelmrichGreenville$1.2M
- Patricia ThompsonBeaufort$649K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.